skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701 (Code C114496)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701

Definition: A cell-based cancer vaccine comprised of dendritic cells (DCs) pulsed with various, synthetic glioma-associated antigen (GAA) peptides, with potential antineoplastic activity. Upon subcutaneous administration, the glioma-associated peptide-loaded DC vaccine SL-701 exposes the immune system to various GAA peptides. This may stimulate both anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against the GAA-expressing glioma cells, which may result in tumor cell lysis.

Label: Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701

NCI Thesaurus Code: C114496 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL472322  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701

External Source Codes: 
PDQ Closed Trial Search ID 759093
PDQ Open Trial Search ID 759093 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C114496
Semantic_Type Cell
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom